Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B

Abstract Background Concerns have been raised regarding changes in lipid profiles among patients with chronic hepatitis B (CHB) during tenofovir alafenamide fumarate (TAF) treatment. We aimed to evaluate the effect of TAF treatment on the lipid profiles of patients with CHB. Methods A total of 430 p...

Full description

Bibliographic Details

Published in:	Virology Journal
Main Authors:	Fei Cao, Tao Fan, Xue Jiang, Jian Wang, Yilin Liu, Li Zhu, Ye Xiong, Shaoqiu Zhang, Zhiyi Zhang, Yifan Pan, Yuanyuan Li, Chao Jiang, Juan Xia, Xiaomin Yan, Jie Li, Xingxiang Liu, Chuanwu Zhu, Rui Huang, Chao Wu
Format:	Article
Language:	English
Published:	BMC 2024-09-01
Subjects:	Tenofovir alafenamide fumarate Triglyceride Total cholesterol Chronic hepatitis B
Online Access:	https://doi.org/10.1186/s12985-024-02515-7